Pharmaceutical composition for parenteral nutrition comprising L- carnitine or acyl L-carnitines

摘要

A glucose solution for drip phleboclysis characterized by the inclusion therein of L-carnitine is disclosed. The presence of L- carnitine improves the muscle tissue absorption and utilization of glucose, thus preventing excessive insulin secretion. This permits the utilization of 10% glucose solutions, and also in excess of 10%, without any risk for the patient even in the case of long-term treatment.